Geode Capital Management’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $933K | Buy |
120,831
+43,364
| +56% | +$335K | ﹤0.01% | 3346 |
|
|
2025
Q1 | $477K | Buy |
77,467
+6,746
| +10% | +$41.6K | ﹤0.01% | 3561 |
|
|
2024
Q4 | $347K | Sell |
70,721
-853
| -1% | -$4.18K | ﹤0.01% | 3715 |
|
|
2024
Q3 | $360K | Buy |
71,574
+66
| +0.1% | +$332 | ﹤0.01% | 3705 |
|
|
2024
Q2 | $294K | Buy |
71,508
+23,812
| +50% | +$97.9K | ﹤0.01% | 3777 |
|
|
2024
Q1 | $363K | Buy |
47,696
+3,352
| +8% | +$25.5K | ﹤0.01% | 3725 |
|
|
2023
Q4 | $370K | Buy |
44,344
+16,470
| +59% | +$137K | ﹤0.01% | 3727 |
|
|
2023
Q3 | $236K | Buy |
27,874
+3,705
| +15% | +$31.3K | ﹤0.01% | 3914 |
|
|
2023
Q2 | $230K | Buy |
24,169
+7,429
| +44% | +$70.6K | ﹤0.01% | 3983 |
|
|
2023
Q1 | $97.1K | Sell |
16,740
-104
| -0.6% | -$603 | ﹤0.01% | 4344 |
|
|
2022
Q4 | $136K | Sell |
16,844
-45
| -0.3% | -$363 | ﹤0.01% | 4278 |
|
|
2022
Q3 | $155K | Buy |
16,889
+8,194
| +94% | +$75.2K | ﹤0.01% | 4348 |
|
|
2022
Q2 | $99K | Sell |
8,695
-15,893
| -65% | -$181K | ﹤0.01% | 4596 |
|
|
2022
Q1 | $521K | Buy |
24,588
+2,123
| +9% | +$45K | ﹤0.01% | 3914 |
|
|
2021
Q4 | $651K | Sell |
22,465
-2,707
| -11% | -$78.4K | ﹤0.01% | 3912 |
|
|
2021
Q3 | $2.46M | Buy |
25,172
+15,043
| +149% | +$1.47M | ﹤0.01% | 3261 |
|
|
2021
Q2 | $1.32M | Buy |
10,129
+598
| +6% | +$77.8K | ﹤0.01% | 3462 |
|
|
2021
Q1 | $1.72M | Buy |
+9,531
| New | +$1.72M | ﹤0.01% | 3327 |
|